Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
24,88 USD | +2,26 % | +0,57 % | -38,37 % |
Resumen de negocios
Número de empleados: 553
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Transformative Medicines
100,0
%
| 78 | 100,0 % | 9 | 100,0 % | -88,02 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 78 | 100,0 % | 9 | 100,0 % | -88,02 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Neil Kumar
FOU | Founder | 45 | 01/01/15 |
Charles Homcy
FOU | Founder | 75 | 01/01/15 |
Founder | 73 | 01/01/15 | |
Brian Stephenson
DFI | Director of Finance/CFO | 43 | 01/10/18 |
Jonathan Fox
PSD | President | 67 | - |
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/04/16 |
Christine Siu
COO | Chief Operating Officer | 47 | 01/01/20 |
Richard Scheller
CTO | Chief Tech/Sci/R&D Officer | 70 | - |
Vikram Bali
IRC | Investor Relations Contact | - | - |
Adora Ndu
LAW | General Counsel | 43 | 01/01/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
James Momtazee
BRD | Director/Board Member | 52 | 01/03/16 |
Founder | 73 | 01/01/15 | |
Fred Hassan
BRD | Director/Board Member | 78 | 17/08/21 |
Charles Homcy
FOU | Founder | 75 | 01/01/15 |
Randal Scott
BRD | Director/Board Member | 66 | 23/06/20 |
Richard Scheller
CTO | Chief Tech/Sci/R&D Officer | 70 | - |
Douglas Dachille
BRD | Director/Board Member | 59 | 17/08/21 |
Ali Satvat
BRD | Director/Board Member | 46 | 01/03/16 |
Andrew Lo
FOU | Founder | 63 | 01/01/15 |
Neil Kumar
FOU | Founder | 45 | 01/01/15 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 189 895 402 | 144 456 085 ( 76,07 %) | 6 191 761 ( 3,261 %) | 76,07 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
LIANBIO 4.75% | 5 002 792 | 4.75% | 1 615 902 $ |
Información de la empresa
BridgeBio Pharma, Inc.
3160 Porter Drive Suite 250
94304, Palo Alto
+650 391 9740
http://www.bridgebio.comVentas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-38,37 % | 4655,78 M | |
-4,66 % | 86,13 mil M | |
+1,32 % | 39,82 mil M | |
-19,27 % | 30,42 mil M | |
+57,86 % | 25,23 mil M | |
-16,09 % | 15,36 mil M | |
-9,14 % | 11,95 mil M | |
-17,69 % | 11,6 mil M | |
-43,00 % | 11,51 mil M | |
+5,24 % | 8710,47 M |
- Bolsa de valores
- Acciones
- Acción BBIO
- Empresa BridgeBio Pharma, Inc.